Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06541301 | PICC-ports Versus Chest - Ports for Long Term Chemotherapy Deliverance in Oncology Patients(PICCHEST) | unknown | N/A | 852 | European Institute of OncologyOTHER | 1 | Nov 19, 2024 | clinicaltrials |
| NCT04304066 | Research for the Molecular Imaging of the PD-L1 Targeting Tracer | unknown | N/A | 50 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT06512896 | Clinical Study on Intraluminal Injection of FOLactis | unknown | N/A | 40 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06469268 | Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period | unknown | N/A | 100 | Shikai WuOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06363201 | Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | unknown | N/A | 40 | Catalysis SLINDUSTRY | 1 | Apr 12, 2024 | clinicaltrials |
| NCT05322512 | Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors | unknown | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 0 | Nov 29, 2023 | clinicaltrials |
| NCT06022276 | Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors | unknown | N/A | 46 | Tianjin Medical University Second HospitalOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT05949775 | Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors | unknown | N/A | 20 | Stemirna TherapeuticsINDUSTRY | 0 | Jul 18, 2023 | clinicaltrials |
| NCT05940181 | A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors | unknown | N/A | 9 | jianming xuOTHER | 1 | Jul 11, 2023 | clinicaltrials |
| NCT05747339 | A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors | unknown | N/A | 50 | Wuxi People's HospitalOTHER | 0 | Jun 13, 2023 | clinicaltrials |
| NCT05359354 | Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors | unknown | N/A | 36 | YueJuan ChengOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT04542863 | The Molecular Imaging Research of F-18 Labeled DX600 PET Probe | unknown | N/A | 100 | Peking University Cancer Hospital & InstituteOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT04214717 | Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor(DC-CIK) | unknown | N/A | 60 | Yantai Yuhuangding HospitalOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT04214730 | Study of NK Combined With Chemotherapy for Advanced Solid Tumor(NK) | unknown | N/A | 60 | Yantai Yuhuangding HospitalOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT05744089 | Home Management of Simple Hydromorphone PCA Pump Mode | unknown | N/A | 50 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT05745454 | A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors | unknown | N/A | 12 | su haichuanOTHER | 0 | Feb 27, 2023 | clinicaltrials |
| NCT05637034 | 68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer | unknown | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Dec 5, 2022 | clinicaltrials |
| NCT05539183 | Collection of Pleural Effusion Fluid | unknown | N/A | 50 | Universitair Ziekenhuis BrusselOTHER | 0 | Sep 14, 2022 | clinicaltrials |
| NCT03373656 | Vaccination for Children of H&O and Their Parents | unknown | N/A | 300 | Children's Cancer Group, ChinaNETWORK | 1 | Jul 26, 2022 | clinicaltrials |
| NCT04750772 | Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer | unknown | N/A | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT05385081 | PREcision Medicine in Cancer in Odense, Denmark(PRECODE) | unknown | N/A | 900 | Odense University HospitalOTHER | 1 | May 23, 2022 | clinicaltrials |
| NCT05380986 | Camrelizumab Combined With Apatinib Mesylate | unknown | N/A | 500 | Henan Cancer HospitalOTHER_GOV | 1 | May 19, 2022 | clinicaltrials |
| NCT04963972 | Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery | unknown | N/A | 272 | Lucid Lane, IncINDUSTRY | 1 | May 10, 2022 | clinicaltrials |
| NCT04407897 | SOFT- Stereotactic Ablative Radiotherapy of Infra-diaphragmatic Soft Tissue Metastases(SOFT) | unknown | N/A | 121 | Herlev HospitalOTHER | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05282784 | Hyperthermia With Flexible Electrode-typed 2-MHz Device During Radiotherapy for Solid Tumors | unknown | N/A | 20 | Yonsei Hyperthermia Study GroupOTHER | 0 | Mar 16, 2022 | clinicaltrials |
| NCT04407676 | Improving Informed Consent for Early Phase Anti-Cancer Trials(CONSENT) | unknown | N/A | 34 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 4, 2022 | clinicaltrials |
| NCT05252975 | Improving Cyberknife Spinal Stereotactic Radiotherapy in Difficult to Treat Cases (IMPRESS)(IMPRESS) | unknown | N/A | 10 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 23, 2022 | clinicaltrials |
| NCT05058937 | A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre(BALLETT) | unknown | N/A | 936 | The Belgian Society of Medical OncologyOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT04989010 | Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors | unknown | N/A | 20 | Wuxi No. 4 People's HospitalOTHER | 1 | Aug 4, 2021 | clinicaltrials |
| NCT04971369 | Safety Study of 89Zr-NY001 PET Imaging in Patients | unknown | N/A | 20 | Wuxi No. 4 People's HospitalOTHER | 1 | Jul 27, 2021 | clinicaltrials |
| NCT04977128 | 89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors | unknown | N/A | 20 | Wuxi No. 4 People's HospitalOTHER | 1 | Jul 26, 2021 | clinicaltrials |
| NCT04175899 | Effectiveness of Pharmacist Intervention on Capecitabine Relative Dose Intensity, Adherence, Knowledge & Safety Among Cancer Patients in Malaysia(POCCP1) | unknown | N/A | 106 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04691713 | CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors | unknown | N/A | 5 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Dec 31, 2020 | clinicaltrials |
| NCT03998345 | Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China | unknown | N/A | 24 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.INDUSTRY | 1 | Sep 9, 2020 | clinicaltrials |
| NCT04367948 | Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma | unknown | N/A | 200 | Peking University Cancer Hospital & InstituteOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT01566019 | Molecular Screening for Cancer Treatment Optimization(MOSCATO 02) | unknown | N/A | 2,150 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT04151186 | A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors | unknown | N/A | 72 | suhaichuanOTHER | 0 | Nov 5, 2019 | clinicaltrials |
| NCT03977766 | Feasibility of a Process of Digital Validation of Chemotherapies in a Day Treatment Unit(CPV2-0) | unknown | N/A | 150 | Institut Paoli-CalmettesOTHER | 0 | Jun 6, 2019 | clinicaltrials |
| NCT01032278 | Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) | unknown | N/A | 597 | M.D. Anderson Cancer CenterOTHER | 1 | May 21, 2019 | clinicaltrials |
| NCT03929965 | Anlotinib in Advanced Solid Tumors With FGFR Alteration | unknown | N/A | 30 | Shanghai Changzheng HospitalOTHER | 1 | Apr 29, 2019 | clinicaltrials |
| NCT03638804 | 89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors | unknown | N/A | 10 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Dec 5, 2018 | clinicaltrials |
| NCT03596593 | Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors(IMPACT) | unknown | N/A | 8,000 | Peking UniversityOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT03047811 | The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors | unknown | N/A | 15 | Fudan UniversityOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02999750 | EXtendedAnalysis for Cancer Treatment | unknown | N/A | 55 | Medical University of ViennaOTHER | 1 | Dec 21, 2016 | clinicaltrials |
| NCT02390986 | An Extension Study of LON002 in Patients With Cancer | unknown | N/A | 50 | LondonPharma Ltd.INDUSTRY | 1 | Mar 18, 2015 | clinicaltrials |
| NCT00003100 | Dietary Soy Isoflavones for the Prevention of Cancer | unknown | N/A | 90 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00169312 | Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations | unknown | N/A | 2,619 | Josephine Ford Cancer CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00349024 | Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer | unknown | N/A | 50 | Children's Cancer and Leukaemia GroupOTHER | 2 | Sep 20, 2013 | clinicaltrials |
| NCT00498992 | Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer | unknown | N/A | 20 | Ingalls Memorial HospitalOTHER | 1 | Sep 20, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Nov 19, 2024source: clinicaltrials